[Status and influencing factors of transition preparation in adolescents with thalassemia major]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiHuang XP +5 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1990 用氩激光小梁成形术(ALT)治疗79例105眼开角型青光眼的4年疗效。总有效率78％,平均眼压下降1.34kPa(10.04mmHg),4年内疗效稳定。全部病例均为最大耐受量药物治疗无效拟作滤过性手术者,ALT术后83％病例在4年内可避免作滤过性手术。失败的23眼中有21眼在ALT后半年内眼压回升,另2眼在第3年回升,18眼(17％)须作滤过性手术。ALT术后42.9％的病例其用药种数减少。年岁较大(>60岁 ...
doaj
[Revision and validation of Liebowitz Social Anxiety Scale for Children and Adolescents]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoSun Z, Li W, Tang X, Yu M.
europepmc +1 more source
[Advances in the application of individualized white-matter functional networks in children and adolescents with attention-deficit/hyperactivity disorder]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiYang HH, Hou JL.
europepmc +1 more source
Zhongguo shiyan zhenduanxue目的 为了解耐药结核病患者的耐药特征。方法 收集2021年9月至2022年9月昆明市第三人民医院结核科收治的208例耐药结核病患者的实验室资料为研究对象，分析其在不同年龄、性别、标本类型、抗结核药物耐药中的占比情况。结果 208例研究对象中。各年龄段耐药青少年5例(2.40%),青年97例(46.64%),中年70例(33.65%),老年36例(17.31%);不同性别中男性130例(62.50%),女性78例(37.50%)。各抗结核药物中单耐药97例(46.63%),多耐药22例(10.58 ...
马志强 +5 more
doaj
[Research Advancements in Gastric Capacity Intervention for Childhood and Adolescent Obesity]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanZhou A, Yang F.
europepmc +1 more source
[Adolescent depressive disorder: prevalence, risk factors, current status of diagnosis and treatment, and challenges]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiCong EZ.
europepmc +1 more source
[Relationship between family trauma, school bullying and suicidal behavior in adolescents: Regulatory effect of <i>DRD2</i> gene polymorphism]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanBai H, Chen Y, Wang K, Xu X.
europepmc +1 more source
[Disease burden and risk factors of myocarditis among children and adolescents aged 0-19 years in China from 1990 to 2021 and projection of future disease burden trends]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiZhao LH, Zhang JX, Zhao ZZ, Wu W.
europepmc +1 more source